BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1768969)

  • 21. In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide-purged marrow in lymphoid malignancies.
    Albin N; Douay L; Fouillard L; Laporte JP; Isnard F; Lesage S; Ozsahin H; Bardinet D; Najman A; Gorin NC
    Bone Marrow Transplant; 1994 Aug; 14(2):253-9. PubMed ID: 7994241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
    Olivieri A; Poloni A; Montanari M; Cantori I; Corvatta L; Masia MC; Curzi L; Mancini S; Leoni P
    J Hematother; 1997 Apr; 6(2):137-44. PubMed ID: 9131443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma interacts with mafosfamide toxicity to normal haematopoietic progenitor cells: impact on in vitro marrow purging.
    Giarratana MC; Gorin NC; Douay L
    Nouv Rev Fr Hematol (1978); 1995; 37(2):125-30. PubMed ID: 7644349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
    Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
    Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
    [No Abstract]   [Full Text] [Related]  

  • 25. Autologous transplantation of chemotherapy-purged PBSC collections from high-risk leukemia patients: a pilot study.
    Lemoli RM; Visani G; Leopardi G; Motta MR; Rizzi S; Testoni N; Curti A; Tura S
    Bone Marrow Transplant; 1999 Feb; 23(3):235-41. PubMed ID: 10084254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple method to detect immature hemopoietic progenitors after in vitro treatment with ASTA-Z 7654.
    Lamana M; Gonzalez R; Camara R; Steegmann JL; Fernandez-Rañada JM
    Prog Clin Biol Res; 1992; 377():35-9. PubMed ID: 1438430
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
    Uckun FM; Stong RC; Youle RJ; Vallera DA
    J Immunol; 1985 May; 134(5):3504-15. PubMed ID: 3884712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P; Pulsoni A; Sandrelli A; Simone F; Amadori S; Meloni G; Mandelli F
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
    Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
    Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J; Fehér I; Kovács P
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.
    Douay L; Hu C; Giarratana MC; Bouchet S; Conlon J; Capizzi RL; Gorin NC
    Blood; 1995 Oct; 86(7):2849-55. PubMed ID: 7670119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of combination drug purging for autologous bone marrow transplantation.
    Jones RJ; Miller CB; Zehnbauer BA; Rowley SD; Colvin OM; Sensenbrenner LL
    Bone Marrow Transplant; 1990 May; 5(5):301-7. PubMed ID: 2350626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
    Jiang R; Bony V; Lopez M
    Prog Clin Biol Res; 1994; 389():23-9. PubMed ID: 7700906
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunological and pharmacological removal of small cell lung cancer cells from bone marrow autografts.
    Humblet Y; Feyens AM; Sekhavat M; Agaliotis D; Canon JL; Symann ML
    Cancer Res; 1989 Sep; 49(18):5058-61. PubMed ID: 2548708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
    Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-mediated marrow purging: mafosfamide in adult acute leukemia in remission. The experience of the Italian study group.
    Rizzoli U; Mangoni L; Carella AM; Aglietta M; Porcellini A; Coleselli P; Angrilli F; Alessandrino EP; Madon E; Locatelli F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():190-4. PubMed ID: 2653502
    [No Abstract]   [Full Text] [Related]  

  • 38. Normal hematopoietic reconstitution following ASTA-Z 7557-purged grafts in the absence of in vitro CFU-GM colony growth.
    Nagler A; Mumcuoglu M; Naparstek E; Or R; Gan S; Slavin S
    Leuk Res; 1993 Jan; 17(1):61-7. PubMed ID: 8429681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful purging of murine plasmacytoma by mafosfamide (ASTA-Z).
    Weiss L; Slavin G; Reich S; Sidi H; Slavin S
    Bone Marrow Transplant; 1994 Jan; 13(1):27-30. PubMed ID: 8019450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated lymphocytes in the marrow cell suspension decrease the mafosfamide-induced CFU-GM cytotoxicity.
    Woźny T; Sawiński K; Kozłowska-Skrzypczak M; Hansz J
    Acta Haematol Pol; 1995; 26(4):367-75. PubMed ID: 8571738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.